Eurythmy Therapy for Constipation

Erdmuthe Worel, Eurythmy Therapy Team Klinik Arlesheim, Andreas Worel

Last update: 14.08.2019

Therapeutic recommendations

  • Contraction and expansion
    This exercise leads to a breathing movement, to finding a balanced rhythm between tensing and letting go.

  • The sound movements “L” and “M”
    have a fluent dreamy quality (“L” is the “wave sound”), through which the etheric body in the area of the abdomen can be stimulated, on the one hand, and at the same time the soul body and ‘I’ -organization can enter into a relationship with the etheric body in such a way that a healthy peristaltic rhythm sets in.

  • Air sound “R”
    It is often helpful to begin in the periphery, which is more dominated by the senses, in order to then approach the more inward metabolic area from there, e.g., with “R”, the “air sound” that strongly sets the soul body in motion.
    First we start small at the periphery, with the fingers, hands, forearms, or with the feet, lower legs, up to the thighs, ascending to slowly approach the congested area, becoming inwardly mobile from the outside to the inside. This can be done actively, depending on the strength and mobility of the patient, or – especially with bedridden patients – passively with the help of the eurythmy therapist, either with or on the feet.

  • Metabolic sounds, earth sounds: “G – K”, “D – T”, “B – G”
    We approach the congested area from the motor-metabolic system when we make very strong movements, e.g., when the whole leg or even the whole person moves. Then it is especially potent with the metabolic sounds “G – K”, “D – T”, “B – G” (“earth sounds”) – also performed with the feet – through which the ‘I’-organization awakens in the activity of the movement and, pushing through, can help the person to come back to himself and again become master in his body.
    If the patient is bedridden, the therapist’s hand under the patient’s feet is required to replace the floor, e.g., when the patient is doing the sound “D” .

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine